The anti-doping case against Kenyan born British cyclist Chris Froome has been dropped by UCI, cycling’s world governing body, clearing him to race in this year’s Tour de France.
Cycling’s four-time Tour de France winner was under investigation after more than the allowed level of legal asthma drug salbutamol was found in his urine following a test in September last year, which showed more than the 1,000-nanogram per millilitre limit of salbutamol was in his system.
Froome said he used the substance, which is permitted without the use of a therapeutic use exemption but only within certain doses, to help manage his asthma.
There had been fears that Froome would not be allowed to defend his Tour de France title but today, the World Anti-Doping Agency (Wada), which worked closely with the UCI, has accepted there was no breach and have recommended the case is dropped.
Froome said he was “grateful and relieved” to put an end to the matter.
“It has been an emotional nine months.
“Thank you to all of those who have supported and believed in me throughout.
“I meant it when I said that I would never dishonour a winner’s jersey and that my results would stand the test of time.
“I have never doubted that this case would be dismissed for the simple reason that I have known throughout I did nothing wrong.”
– Chris Froome
Froome is now expected to line up at the start of the Tour de France on Saturday.